Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $34,056 | 1,986 | 92.9% |
| Consulting Fee | $2,363 | 2 | 6.4% |
| Education | $90.96 | 11 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $82.91 | 4 | 0.2% |
| Gift | $71.50 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $4,311 | 127 | $0 (2024) |
| ABBVIE INC. | $2,841 | 204 | $0 (2024) |
| UCB, Inc. | $2,304 | 108 | $0 (2024) |
| Eisai Inc. | $1,304 | 66 | $0 (2024) |
| EMD Serono, Inc. | $1,284 | 77 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $1,268 | 86 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,246 | 89 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $1,113 | 66 | $0 (2024) |
| Allergan, Inc. | $1,019 | 104 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $1,015 | 79 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,217 | 207 | MDD US Operations, LLC ($499.42) |
| 2023 | $3,826 | 183 | ABBVIE INC. ($606.12) |
| 2022 | $4,536 | 260 | ABBVIE INC. ($566.51) |
| 2021 | $5,799 | 339 | AbbVie Inc. ($759.18) |
| 2020 | $4,971 | 318 | Allergan, Inc. ($425.12) |
| 2019 | $4,571 | 289 | UCB, Inc. ($432.98) |
| 2018 | $4,147 | 269 | UCB, Inc. ($546.43) |
| 2017 | $4,598 | 140 | Biogen, Inc. ($2,745) |
All Payment Transactions
2,005 individual payment records from CMS Open Payments — Page 1 of 81
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: EPILEPSY | ||||||
| 12/20/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Neurology | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: PAIN | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Neurology | ||||||
| 12/06/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $33.84 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/03/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: PAIN | ||||||
| 12/02/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Pain Management | ||||||
| 11/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Neuropsychiatry | ||||||
| 11/22/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Neurology | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Rare Disease | ||||||
| 11/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,170 | 12,253 | $947,373 | $198,965 |
| 2022 | 11 | 1,160 | 10,317 | $846,537 | $189,265 |
| 2021 | 10 | 1,104 | 1,501 | $549,362 | $143,213 |
| 2020 | 11 | 1,151 | 1,627 | $483,656 | $125,901 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 489 | 776 | $300,106 | $72,343 | 24.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 23 | 10,700 | $337,000 | $53,031 | 15.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 293 | 293 | $147,499 | $35,441 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 258 | 356 | $97,365 | $22,197 | 22.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 47 | 47 | $31,185 | $7,482 | 24.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 15 | 36 | $16,752 | $4,112 | 24.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $11,526 | $2,905 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $5,940 | $1,455 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 371 | 561 | $219,912 | $53,946 | 24.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 15 | 8,800 | $255,200 | $43,089 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 322 | 480 | $132,417 | $31,278 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 217 | 217 | $110,019 | $27,820 | 25.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 112 | 112 | $74,928 | $18,942 | 25.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 24 | $14,112 | $3,670 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 18 | $9,846 | $2,461 | 25.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 28 | $8,428 | $2,275 | 27.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 40 | $8,400 | $2,265 | 27.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $8,475 | $2,234 | 26.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $4,800 | $1,285 | 26.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 349 | 528 | $193,638 | $50,016 | 25.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 267 | 386 | $100,740 | $25,827 | 25.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 146 | 146 | $73,309 | $19,326 | 26.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 94 | 96 | $56,448 | $14,611 | 25.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 74 | 74 | $47,806 | $12,272 | 25.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 62 | 114 | $34,314 | $9,354 | 27.3% |
About Dr. Frank Puhalovich, M.D
Dr. Frank Puhalovich, M.D is a Neurology healthcare provider based in Cumming, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548253941.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Puhalovich, M.D has received a total of $36,663 in payments from pharmaceutical and medical device companies, with $4,217 received in 2024. These payments were reported across 2,005 transactions from 90 companies. The most common payment nature is "Food and Beverage" ($34,056).
As a Medicare-enrolled provider, Puhalovich has provided services to 4,585 Medicare beneficiaries, totaling 25,698 services with total Medicare billing of $657,344. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Cumming, GA
- Active Since 08/31/2005
- Last Updated 02/26/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1548253941
Products in Payments
- TYSABRI (Biological) $2,335
- Briviact (Drug) $1,425
- NURTEC ODT (Drug) $1,387
- ZINBRYTA (Biological) $1,321
- APTIOM (Drug) $1,212
- NUPLAZID (Drug) $1,113
- Fycompa (Drug) $1,040
- UBRELVY (Drug) $1,010
- VYEPTI (Biological) $920.38
- NUEDEXTA (Drug) $869.35
- TROKENDI XR (Drug) $824.73
- Aimovig (Biological) $817.96
- QULIPTA (Drug) $757.95
- DUOPA (Drug) $712.10
- BOTOX (Biological) $652.30
- AUBAGIO (Drug) $577.89
- EMGALITY (Drug) $556.17
- ACTHAR (Biological) $518.87
- Gocovri (Drug) $499.42
- AIMOVIG (Biological) $491.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cumming
Dr. Scott Cooper, M.d, M.D
Neurology — Payments: $359,131
Peter Futrell, M.d, M.D
Neurology — Payments: $35,071
Dr. Reginald Hall, Md, MD
Neurology — Payments: $27,477
Dr. Jorge Juncos, M.d, M.D
Neurology — Payments: $19,011
Bernard Drexinger, M.d, M.D
Neurology — Payments: $5,654
Dr. Joseph Mcnamara, D.c, D.C
Neurology